Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006

被引:37
作者
Abrams, Joseph Y. [1 ]
Weintraub, Eric S. [2 ]
Baggs, James M. [2 ]
McCarthy, Natalie L. [2 ]
Schonberger, Lawrence B. [1 ]
Lee, Grace M. [3 ]
Klein, Nicola P. [4 ]
Belongia, Edward A. [5 ]
Jackson, Michael L. [6 ]
Naleway, Allison L. [7 ]
Nordin, James D. [8 ]
Hambidge, Simon J. [9 ]
Belay, Ermias D. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Immunizat Safety Off, Atlanta, GA USA
[3] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[4] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA
[5] Marshfield Clin Res Fdn, Marshfield, WI USA
[6] Grp Hlth Res Inst, Seattle, WA USA
[7] Kaiser Permanente Northwest, Portland, OR USA
[8] HealthPartners Res Fdn, Minneapolis, MN USA
[9] Kaiser Permanente Colorado, Denver, CO USA
关键词
Kawasaki disease; Vaccine Safety Datalink; Adverse events; Vasculitis; INNATE IMMUNITY; IMMUNIZATION; CHILDREN;
D O I
10.1016/j.vaccine.2014.10.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Kawasaki disease is a childhood vascular disorder of unknown etiology. Concerns have been raised about vaccinations being a potential risk factor for Kawasaki disease. Methods: Data from the Vaccine Safety Datalink were collected on children aged 0-6 years at seven managed care organizations across the United States. Defining exposure as one of several time periods up to 42 days after vaccination, we conducted Poisson regressions controlling for age, sex, season, and managed care organization to determine if rates of physician-diagnosed and verified Kawasaki disease were elevated following vaccination compared to rates during all unexposed periods. We also performed case-crossover analyses to control for unmeasured confounding. Results: A total of 1,721,186 children aged 0-6 years from seven managed care organizations were followed for a combined 4,417,766 person-years. The rate of verified Kawasaki disease was significantly lower during the 1-42 days after vaccination (rate ratio = 0.50, 95% CL = 0.27-0.92) and 8-42 days after vaccination (rate ratio = 0.45, 95% CL = 0.22-0.90) compared to rates during unexposed periods. Breaking down the analysis by vaccination category did not identify a subset of vaccines which was solely responsible for this association. The case-crossover analyses revealed that children with Kawasaki disease had lower rates of vaccination in the 42 days prior to symptom onset for both physician-diagnosed Kawasaki disease (rate ratio = 0.79, 95% CL = 0.64-0.97) and verified Kawasaki disease (rate ratio = 038, 95% CL = 0.20-0.75). Conclusions: Childhood vaccinations' studied did not increase the risk of Kawasaki disease; conversely, vaccination was associated with a transient decrease in Kawasaki disease incidence. Verifying and understanding this potential protective effect could yield clues to the underlying etiology of Kawasaki disease. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:382 / 387
页数:6
相关论文
共 24 条
[1]   The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety [J].
Baggs, James ;
Gee, Julianne ;
Lewis, Edwin ;
Fowler, Gabrielle ;
Benson, Patti ;
Lieu, Tracy ;
Naleway, Allison ;
Klein, Nicola P. ;
Baxter, Roger ;
Belongia, Edward ;
Glanz, Jason ;
Hambidge, Simon J. ;
Jacobsen, Steven J. ;
Jackson, Lisa ;
Nordin, Jim ;
Weintraub, Eric .
PEDIATRICS, 2011, 127 :S45-S53
[2]   KAWASAKI SYNDROME - DESCRIPTION OF 2 OUTBREAKS IN THE UNITED-STATES [J].
BELL, DM ;
BRINK, EW ;
NITZKIN, JL ;
HALL, CB ;
WULFF, H ;
BERKOWITZ, ID ;
FEORINO, PM ;
HOLMAN, RC ;
HUNTLEY, CL ;
MEADE, RH ;
ANDERSON, LJ ;
CHEESEMAN, SH ;
FIUMARA, NJ ;
GILFILLAN, RF ;
KEIM, DE ;
MODLIN, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (26) :1568-1575
[3]   T cell activation profiles in Kawasaki syndrome [J].
Brogan, P. A. ;
Shah, V. ;
Clarke, L. A. ;
Dillon, M. J. ;
Klein, N. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (02) :267-274
[4]   Of Mice and Children Lessons From a Kawasaki Mouse Model [J].
Burns, Jane C. .
CIRCULATION, 2012, 125 (12) :1480-1481
[5]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[6]   LACK OF ASSOCIATION OF KAWASAKI DISEASE AFTER IMMUNIZATION IN A COHORT OF INFANTS FOLLOWED FOR MULTIPLE AUTOIMMUNE DIAGNOSES IN A LARGE, PHASE-4 OBSERVATIONAL DATABASE SAFETY STUDY OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE LACK OF ASSOCIATION BETWEEN KAWASAKI DISEASE AND SEVEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE [J].
Center, Kimberly J. ;
Hansen, John R. ;
Lewis, Edwin ;
Fireman, Bruce H. ;
Hilton, Betsy .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (05) :438-440
[7]  
Centers for Disease Control and Prevention, 2014, 2005 2006 US INFL SE
[8]   Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States [J].
Chen, RT ;
Glasser, JW ;
Rhodes, PH ;
Davis, RL ;
Barlow, WE ;
Thompson, RS ;
Mullooly, JP ;
Black, SB ;
Shinefield, HR ;
Vadheim, CM ;
Marcy, SM ;
Ward, JI ;
Wise, RP ;
Wassilak, SG ;
Hadler, SC ;
Swint, E ;
Hardy, JR ;
Payne, T ;
Immanuel, V ;
Benson, P ;
Draket, J ;
Drew, L ;
Mendius, B ;
Ray, P ;
Lewis, N ;
Fireman, BH ;
Jing, J ;
Wulfsohn, M ;
Lugg, MM ;
Osborne, P ;
Rastogi, S ;
Patriarca, P ;
Caserta, V .
PEDIATRICS, 1997, 99 (06) :765-773
[9]   Vaccine Adjuvants: Putting Innate Immunity to Work [J].
Coffman, Robert L. ;
Sher, Alan ;
Seder, Robert A. .
IMMUNITY, 2010, 33 (04) :492-503
[10]   Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas [J].
Falcini, Fernanda ;
Capannini, Serena ;
Rigante, Donato .
PEDIATRIC RHEUMATOLOGY, 2011, 9